AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DELTEX MEDICAL GROUP PLC

Director's Dealing Mar 16, 2015

7593_dirs_2015-03-16_db6ef8e2-4b59-4d06-baa0-8552212566e3.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5181H

Deltex Medical Group PLC

16 March 2015

Deltex Medical Group plc

("Deltex Medical" or "the Company")

Director/PDMR Shareholding

16 March 2015 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that on 13 March 2015 three Directors purchased shares in the Company.

Tim Irish, non-executive Director, notified the Company on 13 March 2015 of the purchase of 500,000 Ordinary Shares at a price of 5.00 pence per Ordinary Share. As a result Mr Irish's shareholding totals 1,848,484 ordinary shares (representing 0.87 per cent. of the issued share capital of Deltex Medical).

Sir Duncan Nichol, non-executive Director, notified the Company on 14 March 2015 of the purchase of 180,000 Ordinary Shares at a price of 5.40 pence per Ordinary Share. As a result Sir Duncan's shareholding totals 1,166,912 ordinary shares (representing 0.55 per cent. of the issued share capital of Deltex Medical).

Paul Mitchell, Finance Director notified the Company on 15 March 2015 of the purchase of 156,981 Ordinary Shares at an average price of 5.41 pence per Ordinary Share. As a result Mr Mitchell's shareholding totals 509,812 ordinary shares (representing 0.24 per cent. of the issued share capital of Deltex Medical).

For further information, please contact:-

Deltex Medical Group plc 01243 774 837

[email protected]
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director
Barry Curtis, Company Secretary
Nominated Adviser & Broker
Arden Partners plc 020 7614 5900
Chris Hardie
Joint Broker

Zeus Capital Limited

Dominic Wilson

John Goold
020 7533 7727
Financial Public Relations
Newgate 020 7653 9850
Tim Thompson
Robyn McConnachie

Ed Treadwell

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFIIVEIRLIE

Talk to a Data Expert

Have a question? We'll get back to you promptly.